urban-gro, Inc. (UGRO) Dividend History

Urban-gro, Inc. (UGRO) is a provider of integrated solutions for the controlled environment agriculture (CEA) industry, specializing in manufacturing and distributing horticultural technology, equipment, and consulting services. The company focuses on creating sustainable and efficient systems for indoor, vertical, and greenhouse farming operations, serving both commercial growers and horticultural entrepreneurs.

1751 Panorama Pt, Lafayette, CO, 80026
Phone: 720-390-3880
Website:

Dividend History

urban-gro, Inc. currently does not pay dividends

Company News

  • In the latest quarter, 4 analysts provided ratings for Urban-gro (NASDAQ:UGRO), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 0 0 0 0 Analysts have recently evaluated Urban-gro and provided 12-month price targets. The average target is $8.0, accompanied by a high estimate of $8.00 and a low estimate of $8.00. This current average has not changed from the previous average price target. Breaking Down Analyst Ratings: A Detailed Examination An in-depth analysis of recent analyst actions unveils how financial experts perceive Urban-gro. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Urban-gro. This insight gives a ...Full story available on Benzinga.com

    Benzinga
  • LAFAYETTE, Colo., May 30, 2024 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ: UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced the appointment of Sadler, Gibb & Associates LLC as its independent registered public accounting firm. Their appointment was made after a thorough evaluation process and has been approved by the Company’s Board of Directors and its Audit Committee.

    GlobeNewswire Inc.
  • Throughout the last three months, 5 analysts have evaluated Urban-gro (NASDAQ:UGRO), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 2 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $7.05, a high estimate of $8.00, and a low estimate of $3.25. This current average has decreased by 3.82% from the previous average price target of $7.33. Exploring Analyst Ratings: An In-Depth Overview An in-depth analysis of recent analyst actions unveils how financial experts perceive Urban-gro. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Eric Beder Small Cap Consumer Research Maintains Buy $8.00 - Eric Beder Small Cap Consumer Research Maintains Buy $8.00 - Eric Des Lauriers Craig-Hallum Lowers Buy $3.25 $6.00 Eric Beder Small Cap Consumer Research Maintains Buy $8.00 $8.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent ...Full story available on Benzinga.com

    Benzinga
  • U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The S&P 500 also rose, gaining, 0.10% to 5,253.70. Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'   Leading and Lagging Sectors   Energy shares jumped by 1.1% on Thursday. In trading on Thursday, communication services shares fell by 0.2%.   Top Headline   Shares of MSC Industrial Direct Co., Inc. (NYSE: MSM) fell over 2% during Thursday’s session after the company reported mixed second-quarter results. MSC Industrial Direct reported second-quarter FY24 net sales decline of 2.7% Y/Y to $935.3 million, missing the consensus of $946.5 million. Adjusted EPS of $1.18, down 18.6%, beating the consensus of $1.16. MSC Industrial reiterated the outlook for FY24 ADS growth of 0%-5%, adjusted operating margin of 12% – 12.8%, and an operating cash flow conversion of more than 125%.   Equities Trading UP   Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 384% to $22.98 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Shares of Xilio Therapeutics, Inc. (NASDAQ:

    Benzinga
    Featured Companies: AVTX DTST MSM PMEC XLO
  • Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...

    Benzinga
Dividend data last updated 06/07/2025 14:43:29 UTC